Literature DB >> 26860988

Early stage squamous cell carcinoma of the lower lip: predictive factors for recurrence.

Y Ozkul1, M Songu1, A Imre1, E Tunc1, Z Ozkul2, S Arslanoglu1, E Pinar1, K Onal1.   

Abstract

OBJECTIVE: This study aimed to evaluate the effect of tumour thickness on other clinicopathological parameters in early stage lower lip squamous cell carcinoma.
METHODS: Forty-six consecutive patients with lower lip squamous cell carcinoma were included in the study. Demographic, clinical and pathological data were retrospectively collected.
RESULTS: The mean follow-up period for all patients was 32.0 ± 18.9 months. Forty-four tumours were staged as T1 and two were T2. Twelve patients underwent neck dissection. Two patients presented with neck metastasis in the follow-up period. Four patients (8.7 per cent) had local recurrence. Correlation analysis revealed a significant relationship between microscopic tumour thickness and local tumour recurrence (r = 0.328, p = 0.045).
CONCLUSION: Surgical margin control is important to prevent local recurrence, especially in thicker tumours. In addition, neck metastasis is rare in early stage lower lip squamous cell carcinoma. A 'wait and see' policy might be preferred in early stage T1 lower lip squamous cell carcinoma cases.

Entities:  

Keywords:  Lip Neoplasms; Recurrence

Mesh:

Year:  2016        PMID: 26860988     DOI: 10.1017/S0022215116000311

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Intraoral stents in preventing adverse radiotherapeutic effects in lip cancer patients.

Authors:  Breno A Rocha; Lucianne M C Lima; Lívia M R Paranaíba; Angel da S Martinez; Maria Betânia de O Pires; Edimilson M de Freitas; Camilla V Vilas Boas; Mário R de Melo Filho
Journal:  Rep Pract Oncol Radiother       Date:  2017-09-01

2.  Management of and risk factors for regional recurrence in upper lip squamous cell carcinoma.

Authors:  Fei Liu; Lei Wang; Shuang Pang; Quancheng Kan
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.